Cim Investment Management Inc Exact Sciences Corp Transaction History

Cim Investment Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$30.35 - $53.15 $7,284 - $12,756	-240 Reduced 2.41%	9,707 $480,000
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $318,005 - $491,083	9,947 New	9,947 $323,000
Q2 2020 Aug 14, 2020	SELL	$55.75 - $92.75 $621,724 - $1.03 Million	-11,152 Closed	0 $0
Q1 2020 May 22, 2020	BUY	$37.9 - $104.44 $11,445 - $31,540	302 Added 2.78%	11,152 $647,000
Q4 2019 Feb 14, 2020	BUY	$77.66 - $99.74 $842,611 - $1.08 Million	10,850 New	10,850 $1 Million

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Cim Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cim Investment Management Inc with notifications on news.